Inventia Healthcare Limited is recalling 11,460 bottles of Chlorthalidone Tablets USP, 25 mg, a blood pressure medication distributed nationwide after the product failed dissolution specifications. The recall was initiated June 5 and was classified as a Class II recall by…
Pharmacy
Boston (Mass.) Children’s Hospital has launched a neurologic drug research program through a new research agreement focused on developing therapies for patients with unmet medical needs. The agreement builds on a strategic collaboration announced in July 2025 with NS Pharma,…
Major drugmakers are advancing therapies that could affect hospital formularies, oncology programs, infectious disease management and obesity care. Here are six recent pharma developments healthcare leaders should know. Here are six recent moves to know:
Retail pharmacies are closing, and the pharmacists who worked in them are leaving, too. Rite Aid filed for bankruptcy in 2023 and shuttered about 800 stores while CVS closed 900 locations beginning in 2021, and Walgreens announced plans to close…
HHS has directed six of its agencies to reduce regulatory barriers associated with clinical trial research to accelerate pharmaceutical development in the U.S. The move — detailed in a road map called Operation TrailBlazer — comes as “a growing share…
Advertisement
The FDA approved 13 new immunotherapies in 2025, down from 22 approvals in 2024, according to the Cancer Research Institute “Cancer Immunotherapy Insights & Impact” report published June 1. The Cancer Research Institute tracks and analyzes FDA cancer immunotherapy approvals…
HHS and the FDA have requested updates to prescribing information for testosterone replacement therapy products, including changes related to age-related hypogonadism, prostate cancer risk and benign prostatic hyperplasia. HHS said it plans to remove a limitation of use stating that…
The Trump administration has escalated its push to reshape global pharmaceutical pricing, opening a formal trade investigation into Germany over what it characterizes as persistent underpayment for innovative drugs — the latest move in a broader campaign to reduce the…
Active drug shortages in the U.S. rose for the second consecutive quarter in 2026, reaching 223 in the first quarter, according to the American Society of Health-System Pharmacists — and the FDA’s database continues to reflect new discontinuations weekly. The…
Eli Lilly has begun denying 340B drug discounts to hospitals that have not submitted claims-level data under its reporting requirements, according to a June 18 news release from the American Hospital Association. “AHA can confirm that Eli Lilly has taken…